The liver transplantation market is likely to hold a valuation of US$ 2,653.4 million by 2033. As of 2023, the market is anticipated to be US$ 1,409.8 million. With advancements in clinical sectors, the liver transplantation market is expected to grow at a CAGR 6.5% from 2023 to 2033.
It is observed that hepatitis C, cirrhosis, and chronic liver failure are the key reasons for liver transplantation. Over the years, there has been a great surge in end-stage liver disease in developed countries, such as the United States. Acute hepatic necrosis due to access alcohol consumption is another reason why the functionality of the liver gets adversely affected.
Request a Sample copy of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1281
The liver transplantation market is anticipated to grow in the coming future, and the advancement of treatment techniques plays a prominent role. Reimbursement policies from the government and some private healthcare organizations have led to a surge in the liver transplantation market.
According to Weforum, 2022, around 130,000 transplants took place in 2020, out of which kidney was leading in organ transplants, tailed by liver and heart. Several companies developing surgery instruments and preservation techniques drive the liver transplant market.
For instance, in June 2022, a Swiss medical team devised a new method to minimize the waiting period for organ transplants. Moreover, the surgeons developed a new technology to keep a damaged liver alive for a few days. However, the team is still observing the patient and working on the same for promising growth.
“New storage techniques for damaged livers and effective research and development in stem cells, tissue engineering, and organogenesis can lessen the transplant waiting list.
Key Takeaways :
- The North American region showed a 29.2% share of the liver transplantation market.
- European nations also show promising market demand in the liver transplantation market, with a share of 20.7%.
- Based on treatment type, liver transplantation surgery dominates the liver transplantation market with a 61.1% global revenue share.
- According to the forecast, 51% of liver transplantation surgeries are done in hospitals, while the rest are done in ambulatory and adult liver transplantation centers.
Recent Developments Detected by FMI in the Liver Transplantation Market:
- In 2022, Jaslok Hospital and Research Center in Mumbai saved two lives with a single liver transplantation surgery. This transplantation surgery, also known as split cadaver liver donation surgery, is where the liver is split into two. It was then used by both an adult and a pediatric recipient simultaneously.
- In August 2022, Integrated Graphene, with a team of scientists, developed an electrochemical biosensor to detect biliary complications in donor livers. The device, Gii-Sens, can detect the quality of the liver before transplantation. It can prevent the development of biliary complications and match the donor-recipient for transplant. According to the makers of Gii-Sens, the device is portable, economical, and responds fast to point-of-care diagnostics.
Key Players:
- Allosource
- Conatus Pharmaceuticals Inc.
- Digna Biotech S.L.
- Dompe Farmaceutici S.p.A.
- Isogenis, Inc.
- RedHill Biopharma Ltd.
- Thompson Surgical
- Integra Life Sciences
- Baxter International Inc.
- XVIVO
- VirTech Bio
- Vital Therapies
- HepaTx
- Humedics
Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-1281
Key Segments Profiled in the Global Liver Transplantation Market:
By Treatment Type:
- Liver Transplantation Surgery
- Post-Surgery Anti-Rejection Treatment
- Cyclosporine
- Tacrolimus
- Sirolimus Prednisone Azathioprine
- Mycophenolate Mofetil
By End Use:
- Hospitals
- Adult Liver Transplantation Centers
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
